These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 22641969)
21. Prescribing practices and the prescription drug epidemic: physician intervention strategies. Smith DE J Psychoactive Drugs; 2012; 44(1):68-71. PubMed ID: 22641967 [TBL] [Abstract][Full Text] [Related]
22. Effectiveness of notification and group education in modifying prescribing of regulated analgesics. Anderson JF; McEwan KL; Hrudey WP CMAJ; 1996 Jan; 154(1):31-9. PubMed ID: 8542565 [TBL] [Abstract][Full Text] [Related]
23. Passage of a prescription drug abuse bill in the spring 2011 Nebraska unicameral. Kreifels E Nebr Nurse; 2011; 44(3):6. PubMed ID: 22013653 [No Abstract] [Full Text] [Related]
24. The Minnesota Prescription Monitoring Program. Herman C Northwest Dent; 2011; 90(2):33-5. PubMed ID: 21667591 [TBL] [Abstract][Full Text] [Related]
26. Prescription drug control and dispensing. Md Med J; 1990 Jan; 39(1):47-52. PubMed ID: 2308488 [TBL] [Abstract][Full Text] [Related]
27. What you need to know: guidelines to medical practitioners for proper maintenance of drugs and dispensing records (including controlled drugs). Yee SK Singapore Med J; 1998 Nov; 39(11):520-2. PubMed ID: 10067392 [No Abstract] [Full Text] [Related]
28. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse. Butler SF; Budman SH; Licari A; Cassidy TA; Lioy K; Dickinson J; Brownstein JS; Benneyan JC; Green TC; Katz N Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1142-54. PubMed ID: 18932173 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation of prescription practices and of the rational use of medicines in Niger]. Mallet HP; Njikam A; Scouflaire SM Sante; 2001; 11(3):185-93. PubMed ID: 11641083 [TBL] [Abstract][Full Text] [Related]
33. Prescription drug use and abuse. Meadows M FDA Consum; 2001; 35(5):18-24. PubMed ID: 11697087 [No Abstract] [Full Text] [Related]
35. Determining educational needs in the physician's office. Manning PR; Lee PV; Denson TA; Gilman NJ JAMA; 1980 Sep; 244(10):1112-5. PubMed ID: 7411764 [TBL] [Abstract][Full Text] [Related]
36. Out of the medicine closet: time to talk straight about prescription drug abuse. Haller C; James L Clin Pharmacol Ther; 2010 Sep; 88(3):279-82. PubMed ID: 20725072 [No Abstract] [Full Text] [Related]
37. Provider detailing: an intervention to decrease prescription opioid deaths in Utah. Cochella S; Bateman K Pain Med; 2011 Jun; 12 Suppl 2():S73-6. PubMed ID: 21668760 [TBL] [Abstract][Full Text] [Related]
38. New Drug Enforcement Administration guideline for communicating controlled substance prescriptions to pharmacies. Drug Enforcement Adminstration U S Department of Justice J Pain Palliat Care Pharmacother; 2011; 25(1):83-9. PubMed ID: 21426229 [TBL] [Abstract][Full Text] [Related]
39. Drug abuse related to prescribing practices. JAMA; 1982 Feb; 247(6):864-6. PubMed ID: 7057570 [No Abstract] [Full Text] [Related]
40. Training the next generation of providers in addiction medicine. Rasyidi E; Wilkins JN; Danovitch I Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]